메뉴 건너뛰기




Volumn 46, Issue 1, 2008, Pages 9-16

Medicaid preferred drug lists' costs to physicians

Author keywords

Administrative costs; Medicaid formularies; Medicare part D; Physician prescribing patterns; Prescription drug coverage

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 37649025669     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31814b8245     Document Type: Article
Times cited : (8)

References (41)
  • 1
    • 73349119893 scopus 로고    scopus 로고
    • National Health Expenditures Data, Centers for Medicare and Medicaid Services, Office of the Actuary, April 26, Available at:, Accessed May 30
    • National Health Expenditures Data, Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group [Centers for Medicare and Medicaid Services web site]. April 26, 2006. Available at: http://www.cms.hhs.gov/NationalHealthExpendData. Accessed May 30, 2007.
    • (2006) National Health Statistics Group [Centers for Medicare and Medicaid Services web site]
  • 3
    • 37649025600 scopus 로고    scopus 로고
    • Smith V, Gifford K, Ellis E, et al. Medicaid Budgets, Spending and Policy Initiatives in State Fiscal Years 2005 and 2006: Results From a 50-State Survey. Washington, DC: The Kaiser Commission on Medicaid and the Uninsured [Kaiser Family Foundation web site]. October 2005. Available at: http://www.kff.org/medicaid/upload/Medicaid-Budgets-Spending-and-Policy- Initiatives-in-State-Fiscal-Years-2005-and-2006-report.pdf. Accessed May 30, 2007.
    • Smith V, Gifford K, Ellis E, et al. Medicaid Budgets, Spending and Policy Initiatives in State Fiscal Years 2005 and 2006: Results From a 50-State Survey. Washington, DC: The Kaiser Commission on Medicaid and the Uninsured [Kaiser Family Foundation web site]. October 2005. Available at: http://www.kff.org/medicaid/upload/Medicaid-Budgets-Spending-and-Policy- Initiatives-in-State-Fiscal-Years-2005-and-2006-report.pdf. Accessed May 30, 2007.
  • 5
    • 34248546143 scopus 로고    scopus 로고
    • Impact of Medicaid prior authorization on angiotensin-receptor blockers: Can policy promote rational prescribing?
    • Fischer MA, Choudhry NK, Winkelmayer WC. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff. 2007;26:800-807.
    • (2007) Health Aff , vol.26 , pp. 800-807
    • Fischer, M.A.1    Choudhry, N.K.2    Winkelmayer, W.C.3
  • 6
    • 0001912315 scopus 로고
    • Drug formulary restrictions as a cost-containment policy in Medicaid programs
    • Moore WJ, Newman RJ. Drug formulary restrictions as a cost-containment policy in Medicaid programs. J Law Econ. 1993;36:71-97.
    • (1993) J Law Econ , vol.36 , pp. 71-97
    • Moore, W.J.1    Newman, R.J.2
  • 7
    • 0029075682 scopus 로고
    • Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients
    • Smalley WE, Griffin MR, Fought RL, et al. Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med. 1995;15:1612-1617.
    • (1995) N Engl J Med , vol.15 , pp. 1612-1617
    • Smalley, W.E.1    Griffin, M.R.2    Fought, R.L.3
  • 8
    • 1542283605 scopus 로고    scopus 로고
    • Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: Direct comparison of randomised and observational evaluations
    • Schneeweiss S, Maclure M, Carleton B, et al. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ. 2004;328:560-567.
    • (2004) BMJ , vol.328 , pp. 560-567
    • Schneeweiss, S.1    Maclure, M.2    Carleton, B.3
  • 9
    • 8644290981 scopus 로고    scopus 로고
    • Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors
    • Fischer MA, Schneeweiss S, Avorn J, et al. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004;351:2187-2194.
    • (2004) N Engl J Med , vol.351 , pp. 2187-2194
    • Fischer, M.A.1    Schneeweiss, S.2    Avorn, J.3
  • 10
    • 14844312041 scopus 로고    scopus 로고
    • Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid
    • Murawski M, Abdelgawad T. Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid. Am J Manag Care. 2005;11:SP35-SP42.
    • (2005) Am J Manag Care , vol.11
    • Murawski, M.1    Abdelgawad, T.2
  • 11
    • 20044386365 scopus 로고    scopus 로고
    • Medicaid cost containment and access to prescription drugs
    • Cunningham PJ. Medicaid cost containment and access to prescription drugs. Health Aff. 2005;24:780-789.
    • (2005) Health Aff , vol.24 , pp. 780-789
    • Cunningham, P.J.1
  • 12
    • 0000898862 scopus 로고    scopus 로고
    • Prior authorization programs: A critical review of the literature
    • MacKinnon NJ, Kumar R. Prior authorization programs: a critical review of the literature. J Manag Care Pharm. 2001;4:297-302.
    • (2001) J Manag Care Pharm , vol.4 , pp. 297-302
    • MacKinnon, N.J.1    Kumar, R.2
  • 13
    • 4344699183 scopus 로고    scopus 로고
    • Benefits and risks of increasing restrictions on access to costly drugs in Medicaid
    • Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Aff. 2004;23:135-146.
    • (2004) Health Aff , vol.23 , pp. 135-146
    • Soumerai, S.B.1
  • 14
    • 0033092323 scopus 로고    scopus 로고
    • Who bears the burden of Medicaid drug copayment polices?
    • Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment polices? Health Aff. 1999;18:201-212.
    • (1999) Health Aff , vol.18 , pp. 201-212
    • Stuart, B.1    Zacker, C.2
  • 15
    • 0028169466 scopus 로고
    • Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
    • Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650-655.
    • (1994) N Engl J Med , vol.331 , pp. 650-655
    • Soumerai, S.B.1    McLaughlin, T.J.2    Ross-Degnan, D.3
  • 16
    • 0035941514 scopus 로고    scopus 로고
    • Adverse events associated with prescription drug cost-sharing among poor and elderly persons
    • Tamblyn R, Laprise R, Hanley J, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-429.
    • (2001) JAMA , vol.285 , pp. 421-429
    • Tamblyn, R.1    Laprise, R.2    Hanley, J.3
  • 17
    • 37649004339 scopus 로고    scopus 로고
    • National Pharmaceutical Council, Available at:, Accessed May 30
    • Owens MK. State Medicaid program issues: preferred drug lists. National Pharmaceutical Council. 2004. Available at: http://www.npcnow.org/resources/ PDFs/PDLbrief.pdf. Accessed May 30, 2007.
    • (2004) State Medicaid program issues: Preferred drug lists
    • Owens, M.K.1
  • 18
    • 37649012248 scopus 로고    scopus 로고
    • Kaiser Commission on Medicaid, and the Uninsured. Prior authorization for Medicaid prescription drugs in five states: lessons for policy makers [Kaiser Family Foundation web site]. April 2003. Available at: http://www.kff.org/ medicaid/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14324. Accessed May 30, 2007.
    • Kaiser Commission on Medicaid, and the Uninsured. Prior authorization for Medicaid prescription drugs in five states: lessons for policy makers [Kaiser Family Foundation web site]. April 2003. Available at: http://www.kff.org/ medicaid/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14324. Accessed May 30, 2007.
  • 19
    • 34250310906 scopus 로고    scopus 로고
    • Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?
    • Ketcham JD, Epstein AJ. Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives? Pharmacoeconomics. 2007;24(Suppl 3):27-40.
    • (2007) Pharmacoeconomics , vol.24 , Issue.SUPPL. 3 , pp. 27-40
    • Ketcham, J.D.1    Epstein, A.J.2
  • 20
    • 0242334026 scopus 로고    scopus 로고
    • Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: Spillover effects of a restrictive drug formulary
    • Wang YR, Pauly MV, Lin YA. Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. Am J Manag Care. 2003;9:686-696.
    • (2003) Am J Manag Care , vol.9 , pp. 686-696
    • Wang, Y.R.1    Pauly, M.V.2    Lin, Y.A.3
  • 21
    • 24144487013 scopus 로고    scopus 로고
    • Spillover effects of restrictive drug formularies on physician prescribing behavior: Evidence from Medicaid
    • Wang YR, Pauly MV. Spillover effects of restrictive drug formularies on physician prescribing behavior: evidence from Medicaid. J Econ Manag Strat. 2005;14:755-773.
    • (2005) J Econ Manag Strat , vol.14 , pp. 755-773
    • Wang, Y.R.1    Pauly, M.V.2
  • 22
    • 8644243926 scopus 로고    scopus 로고
    • Prior-authorization programs for controlling drug spending
    • Hamel MB, Epstein AM. Prior-authorization programs for controlling drug spending. N Engl J Med. 2004;3 51:2156 -2158.
    • (2004) N Engl J Med , vol.3 , Issue.51 , pp. 2156-2158
    • Hamel, M.B.1    Epstein, A.M.2
  • 23
    • 0042967778 scopus 로고    scopus 로고
    • Costs of health care administration in the United States and Canada
    • Woolhandler S, Campbell T, Himmelstein DU. Costs of health care administration in the United States and Canada. N Engl J Med. 2003;349:768-775.
    • (2003) N Engl J Med , vol.349 , pp. 768-775
    • Woolhandler, S.1    Campbell, T.2    Himmelstein, D.U.3
  • 24
    • 28444455223 scopus 로고    scopus 로고
    • The cost of health insurance administration in California: Estimates for insurers, physicians and hospitals
    • Kahn JG, Kronick R, Kreger M, et al. The cost of health insurance administration in California: estimates for insurers, physicians and hospitals. Health Aff. 2005;24:1629-1639.
    • (2005) Health Aff , vol.24 , pp. 1629-1639
    • Kahn, J.G.1    Kronick, R.2    Kreger, M.3
  • 25
    • 33646469627 scopus 로고    scopus 로고
    • The economic burden associated with prior authorizations in an allergist office
    • Bukstein DA, Cherayil GA, Gepner AD, et al. The economic burden associated with prior authorizations in an allergist office. Allergy Asthma Proc. 2006;27:119-122.
    • (2006) Allergy Asthma Proc , vol.27 , pp. 119-122
    • Bukstein, D.A.1    Cherayil, G.A.2    Gepner, A.D.3
  • 27
    • 37649014885 scopus 로고    scopus 로고
    • Holahan J, Ghosh A. Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries 2003 [Kaiser Commission on Medicaid and the Uninsured web site]. July 2005. Available at: http://www.kff.org/medicaid/upload/ 7346%20Dual%20Eligibles_Enrollment%20and%20Spending_ Beneficiaries_Final_revised%207_28.pdf. Accessed May 30, 2007.
    • Holahan J, Ghosh A. Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries 2003 [Kaiser Commission on Medicaid and the Uninsured web site]. July 2005. Available at: http://www.kff.org/medicaid/upload/ 7346%20Dual%20Eligibles_Enrollment%20and%20Spending_ Beneficiaries_Final_revised%207_28.pdf. Accessed May 30, 2007.
  • 28
    • 37649005043 scopus 로고    scopus 로고
    • Medicare program: Medicare prescription drug benefit
    • Department of Health and Human Services, Centers for Medicare and Medicaid Services, Available at: ess, Accessed May 30, 2007
    • Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare program: Medicare prescription drug benefit. Fed Regist. 2005;70:4351. Available at: http://a257.g.akamaitech.net/7/257/2422/ 01jan20051800/edocket.access.gpo.gov/2005/pdf/051321.pdf. Accessed May 30, 2007.
    • (2005) Fed Regist , vol.70 , pp. 4351
  • 31
    • 14844320775 scopus 로고    scopus 로고
    • Physicians' prescribing responses to a restricted, formulary: The impact of Medicaid preferred drug lists in Illinois and Louisiana
    • Virabhak S, Shinogle JA. Physicians' prescribing responses to a restricted, formulary: the impact of Medicaid preferred drug lists in Illinois and Louisiana. Am J Manag Care. 2005;11:SP14-SP20.
    • (2005) Am J Manag Care , vol.11
    • Virabhak, S.1    Shinogle, J.A.2
  • 32
    • 14844312887 scopus 로고    scopus 로고
    • The effects of access restrictions on the vintage of drugs used by Medicaid, enrollees
    • Lichtenberg FR. The effects of access restrictions on the vintage of drugs used by Medicaid, enrollees. Am J Manag Care. 2005;11:SP7-SP13.
    • (2005) Am J Manag Care , vol.11
    • Lichtenberg, F.R.1
  • 33
    • 37649008995 scopus 로고    scopus 로고
    • Centers for Medicare and Medicaid Services. Estimated prescriptions filled for Medicare beneficiaries with drug coverage through 5-31-06 [Centers for Medicare and. Medicaid Services web site]. July 17, 2006. Available at: http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/Downloads/ PartDPrescriptionClaimsData.zip. Accessed May 30, 2007.
    • Centers for Medicare and Medicaid Services. Estimated prescriptions filled for Medicare beneficiaries with drug coverage through 5-31-06 [Centers for Medicare and. Medicaid Services web site]. July 17, 2006. Available at: http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/Downloads/ PartDPrescriptionClaimsData.zip. Accessed May 30, 2007.
  • 36
    • 1642630071 scopus 로고    scopus 로고
    • United States Department of Labor, Bureau of Labor Statistics, online database, May 2005. Available at:, Accessed February 23
    • United States Department of Labor, Bureau of Labor Statistics, Occupational Employment Statistics [online database]. May 2005. Available at: http://data.bls.gov/oes/search.do. Accessed February 23, 2007.
    • (2007) Occupational Employment Statistics
  • 37
    • 33745824237 scopus 로고    scopus 로고
    • Patient-reported under use of prescription medications: A comparison of nine surveys
    • Kirking DM, Lee .JA, Ellis JJ, et al. Patient-reported under use of prescription medications: a comparison of nine surveys. Med Care Res Rev. 2006;63:427-446.
    • (2006) Med Care Res Rev , vol.63 , pp. 427-446
    • Kirking, D.M.1    Lee, J.A.2    Ellis, J.J.3
  • 39
    • 0018111956 scopus 로고
    • Physician participation in state Medicaid programs
    • Sloan F, Mitchell J, Cromwell J. Physician participation in state Medicaid programs. J Hum Resour. 1978;13(Suppl):211-245.
    • (1978) J Hum Resour , vol.13 , Issue.SUPPL. , pp. 211-245
    • Sloan, F.1    Mitchell, J.2    Cromwell, J.3
  • 40
    • 37649011854 scopus 로고    scopus 로고
    • Barton: updated estimates of spending for the Medicare prescription drug program [Congressional Budget Office web site, March 4, 2005. Available at: Accessed May 30
    • Holtz-Eakin D. Letter to the Honorable Joe Barton: updated estimates of spending for the Medicare prescription drug program [Congressional Budget Office web site]. March 4, 2005. Available at: http://cbo.gov/showdoc.cfm?index= 6139&sequence=0 Accessed May 30, 2007.
    • (2007) Letter to the Honorable Joe
    • Holtz-Eakin, D.1
  • 41
    • 0026759847 scopus 로고
    • Hidden overhead costs: Is Canada's system really less expensive?
    • Danzon PM. Hidden overhead costs: is Canada's system really less expensive? Health Aff. 1992;11:21-43.
    • (1992) Health Aff , vol.11 , pp. 21-43
    • Danzon, P.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.